Aptamer-functionalized peptide H3CR5C as a novel nanovehicle for codelivery of fasudil and miRNA-195 targeting hepatocellular carcinoma
about
Recent advances in hepatocellular carcinoma therapy.Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma.Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment.
P2860
Aptamer-functionalized peptide H3CR5C as a novel nanovehicle for codelivery of fasudil and miRNA-195 targeting hepatocellular carcinoma
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Aptamer-functionalized peptide ...... eting hepatocellular carcinoma
@ast
Aptamer-functionalized peptide ...... eting hepatocellular carcinoma
@en
type
label
Aptamer-functionalized peptide ...... eting hepatocellular carcinoma
@ast
Aptamer-functionalized peptide ...... eting hepatocellular carcinoma
@en
prefLabel
Aptamer-functionalized peptide ...... eting hepatocellular carcinoma
@ast
Aptamer-functionalized peptide ...... eting hepatocellular carcinoma
@en
P2093
P2860
P3181
P356
P1476
Aptamer-functionalized peptide ...... eting hepatocellular carcinoma
@en
P2093
Dandan Zhang
Gaolin Liu
Guanhua Zhu
Jigang Zhang
Shengying Gu
P2860
P304
P3181
P356
10.2147/IJN.S108128
P407
P577
2016-01-01T00:00:00Z